Jason M. Samuels

General Surgery

719 Thompson Ln Ste 22200
Nashville, TN 37204

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 63 publications

Patient-Reported Continuity of GLP-1 Receptor Agonist Therapy.

Patient-Reported Continuity of GLP-1 Receptor Agonist Therapy.

Journal: Obesity science & practice

Published: May 06, 2026

Obesity-Related Metabolites are Associated with Incident Coronary Heart Disease and Respond to Metabolic and Bariatric Surgery.

Obesity-Related Metabolites are Associated with Incident Coronary Heart Disease and Respond to Metabolic and Bariatric Surgery.

Journal: medRxiv : the preprint server for health sciences

Published: April 10, 2026

Preoperative GLP-1 Receptor Agonist Use and Weight Loss Outcomes Following Bariatric Surgery.

Preoperative GLP-1 Receptor Agonist Use and Weight Loss Outcomes Following Bariatric Surgery.

Journal: Annals of surgery

Published: January 27, 2026

Body Composition Changes After Bariatric Surgery or Treatment With GLP-1 Receptor Agonists.

Body Composition Changes After Bariatric Surgery or Treatment With GLP-1 Receptor Agonists.

Journal: JAMA network open

Published: January 09, 2026

Obesity Treatment Pathways and Implementation in Health Systems.

Obesity Treatment Pathways and Implementation in Health Systems.

Journal: Obesity science & practice

Published: November 21, 2025

Prevalence of Pre-Clinical Obesity Among US Adults Receiving Medical and Surgical Obesity Treatment.

Prevalence of Pre-Clinical Obesity Among US Adults Receiving Medical and Surgical Obesity Treatment.

Journal: Obesity (Silver Spring, Md.)

Published: November 09, 2025

Weight loss from glucagon-like peptide-1 receptor agonists by genetic factors in adults with type 2 diabetes.

Weight loss from glucagon-like peptide-1 receptor agonists by genetic factors in adults with type 2 diabetes.

Journal: Diabetes research and clinical practice

Published: October 28, 2025

Temporal changes in circulating metabolites after metabolic and bariatric surgery and risk of incident coronary heart disease: evidence from prospective cohort and nested case-control studies.

Temporal changes in circulating metabolites after metabolic and bariatric surgery and risk of incident coronary heart disease: evidence from prospective cohort and nested case-control studies.

Journal: International journal of surgery (London, England)

Published: September 06, 2025

Real-world titration, persistence & weight loss of semaglutide and tirzepatide in an academic obesity clinic.

Real-world titration, persistence & weight loss of semaglutide and tirzepatide in an academic obesity clinic.

Journal: Diabetes, obesity & metabolism

Published: June 09, 2025

Shifting obesity treatment paradigms: Trends of glucagon-like peptide-1 receptor agonists and bariatric surgery in the United States.

Shifting obesity treatment paradigms: Trends of glucagon-like peptide-1 receptor agonists and bariatric surgery in the United States.

Journal: Diabetes, obesity & metabolism

Published: April 17, 2025

Reduced Risk of Cardiovascular Diseases After Bariatric Surgery Based on the New Predicting Risk of Cardiovascular Disease EVENTs Equations.

Reduced Risk of Cardiovascular Diseases After Bariatric Surgery Based on the New Predicting Risk of Cardiovascular Disease EVENTs Equations.

Journal: Journal of the American Heart Association

Published: March 07, 2025

Total Alimentary Limb Length Is Not Associated with Weight Loss Following Proximal Roux-en-Y Gastric Bypass.

Total Alimentary Limb Length Is Not Associated with Weight Loss Following Proximal Roux-en-Y Gastric Bypass.

Journal: Obesity surgery

Published: January 25, 2025

Showing 1-12 of 63

Last Updated: 09/26/2026